CRC has an immunosuppressive TME which stops the development of an efficient response to ICB therapies. There exists As a result an urgent should establish the approaches reprogram this suppressive TME in an effort to increase immunotherapy efficacy. In The present review, we applied CRISPR KO screens to find genes https://arv-82546790.qodsblog.com/28563122/new-step-by-step-map-for-tussilagone